Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Tarsy

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Parkinsonism & Related Disorders|April 16, 2013
Loss of benefit in VIM thalamic deep brain stimulation (DBS) for essential tremor (ET): how prevalent is it?Ludy C Shih, Kathrin LaFaver, Chen Lim, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|July 22, 2015
Comparison of VIM and STN DBS for Parkinsonian Resting and Postural/Action TremorRaminder Parihar, Ron Alterman, Efstathios Papavassiliou, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
Thalamic and subthalamic deep brain stimulation for parkinsonian tremor: are two circuits involved?Omesh Kulkarni, Kathrin Lafaver, Efstathios Papavassiliou, et al.
Parkinsonism & Related Disorders|February 6, 2014
Phonemic verbal fluency decline after subthalamic nucleus deep brain stimulation does not depend on number of microelectrode recordings or lead tip placementKara M Smith, Margaret O'Connor, Efstathios Papavassiliou, et al.
Stereotactic and Functional Neurosurgery|March 15, 2006
Progression of Parkinson's disease following thalamic deep brain stimulation for tremorDaniel Tarsy, Lisa Scollins, Kristin Corapi, et al.
Parkinsonism & Related Disorders|July 14, 2016
Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxinsPushpa Narayanaswami, Thomas Geisbush, Andrew Tarulli, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 15, 2010
Quantifying muscle asymmetries in cervical dystonia with electrical impedance: a preliminary assessmentCodrin Lungu, Andrew W Tarulli, Daniel Tarsy, et al.
Journal of Clinical Psychopharmacology|June 11, 2009
Tardive dyskinesia due to aripiprazole: report of 2 casesCodrin Lungu, Pratibha G Aia, Ludy C Shih, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 26, 2006
End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulationDiana Apetauerova, R Kevin Ryan, Susie I Ro, et al.
Neuro-Degenerative Diseases|September 12, 2016
Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder CenterAllison K Graebner, Daniel Tarsy, Ludy C Shih, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Parkinsonism & Related Disorders|April 16, 2013
Loss of benefit in VIM thalamic deep brain stimulation (DBS) for essential tremor (ET): how prevalent is it?Ludy C Shih, Kathrin LaFaver, Chen Lim, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|July 22, 2015
Comparison of VIM and STN DBS for Parkinsonian Resting and Postural/Action TremorRaminder Parihar, Ron Alterman, Efstathios Papavassiliou, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
Thalamic and subthalamic deep brain stimulation for parkinsonian tremor: are two circuits involved?Omesh Kulkarni, Kathrin Lafaver, Efstathios Papavassiliou, et al.
Parkinsonism & Related Disorders|February 6, 2014
Phonemic verbal fluency decline after subthalamic nucleus deep brain stimulation does not depend on number of microelectrode recordings or lead tip placementKara M Smith, Margaret O'Connor, Efstathios Papavassiliou, et al.
Stereotactic and Functional Neurosurgery|March 15, 2006
Progression of Parkinson's disease following thalamic deep brain stimulation for tremorDaniel Tarsy, Lisa Scollins, Kristin Corapi, et al.
Parkinsonism & Related Disorders|July 14, 2016
Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxinsPushpa Narayanaswami, Thomas Geisbush, Andrew Tarulli, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 15, 2010
Quantifying muscle asymmetries in cervical dystonia with electrical impedance: a preliminary assessmentCodrin Lungu, Andrew W Tarulli, Daniel Tarsy, et al.
Journal of Clinical Psychopharmacology|June 11, 2009
Tardive dyskinesia due to aripiprazole: report of 2 casesCodrin Lungu, Pratibha G Aia, Ludy C Shih, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 26, 2006
End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulationDiana Apetauerova, R Kevin Ryan, Susie I Ro, et al.
Neuro-Degenerative Diseases|September 12, 2016
Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder CenterAllison K Graebner, Daniel Tarsy, Ludy C Shih, et al.
Pageof 6